A simpler method of analyzing blood samples for Alzheimer’s disease has been tested in a large multicenter study led by Lund University in Sweden. “This…
Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as Ozempic and Wegovy), are now drawing increased attention…
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer’s disease (AD), but its role in the brain was…
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have discovered a new way that neurons act in neurodegeneration by using…
Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies—medications that lower blood sugar and reduce the…
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis…
A natural compound found in everyday fruits and vegetables may hold the key to protecting nerve cells—and it’s showing promise as a potential treatment for…
A new University of Otago—Ōtākou Whakaihu Waka study has found a link between our eye health and dementia.
Researchers have discovered that increased blood flow leads to stiffness in the hippocampus, a region of the brain that plays important roles in learning and…
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that regulate higher cognitive brain functions such as personality, behavior, and…